Biologics Manufacturing Articles and Resources

Latest Articles

What the Heck is a Mycoplasma and Why Doesn’t Anyone Like Them?

The global bioburden testing market for bio-pharma contamination is approximately $10B, with over 350M tests run annually. LexaGene provides early detection for mycoplasma, aiding in validating product quality for biopharmaceutical manufacturers.

Building Screening and Surveillance Confidence in Bioprocessing

Single-use manufacturing has provided for a large degree of flexibility in terms of production volumes but have also brought about efficiencies in sterility control by reducing hands on cleaning and sterilization necessary for stainless steel.

Microbial QC Testing in the Manufacture of Biopharmaceuticals

Contamination control of bioprocessing cell lines is essential. The same environments that encourage desirable microbiological growth also encourage growth of undesirable contaminants including yeasts, molds, mycoplasma, bacteria, and viruses.

Latest Resources

December 27, 2021
See how easy to use the MiQLabTM system is to detect pathogens and other molecular markers for a wide range of point-of-need applications.

November 18, 2021
With the advancement of technologies such as CRISPR and CAR-T therapies, there has been a significant increase in the development and production of biologic drugs, Advanced Therapeutic Medicinal Products (ATMP) and Cell and Gene Therapies (CGT).

November 18, 2021
See how easy to use the MiQLab system is to detect pathogens and other molecular markers for a wide range of point-of-need applications.  

Next Page »